Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplantation, Published online: 09 May 2023; doi:10.1038/s41409-023-01985-7Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Source: Bone Marrow Transplantation - Category: Hematology Authors: Giuliano Filippini Vel ázquez Myriam Labopin Johanna Tischer Anna Maria Raiola Emanuele Angelucci Alexander D. Kulagin Piero Galieni Arancha Berm údez Claude-Eric Bulabois Nicolaus Kr öger Jos é Luis Díez-Martín Mi Kwon Arnon Nagler Christoph Schmid Source Type: research
More News: Acute Leukemia | Bone Marrow Transplant | Hematology | Leukemia | Stem Cell Therapy | Stem Cells | Study | Transplants